Key result
A cTnI, BUN, and LVFS model identifies VA risk in pediatric acute myocarditis with ~0.87 AUC.
Why the study?
Early identification of ventricular arrhythmia risk in children with acute myocarditis is challenging because existing tools lack pediatric targeting and patients often do not present with arrhythmias at admission.
Observational (n=312)
No
A simple scoring model based on cTnI, BUN, and LVFS can effectively identify children with acute myocarditis at high risk for early ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
May warrant closer VA monitoring in high-risk pediatric acute myocarditis; hypothesis-generating pending prospective validation before adoption.
Early identification of ventricular arrhythmia (VA) risk in children with acute myocarditis (AMC) is challenging, as existing tools lack pediatric targeting. AMC’s non-specific early symptoms in children lead to underdiagnosis. VA, a major complication of AMC, is linked to poor prognosis, but not all cases present at admission, highlighting the need for simple, accessible predictive indicators. This retrospective single-center study included 312 children (1 month − 17 years) with AMC (2021–2024), divided into a training set (n = 208, 2021–2023) and validation set (n = 104, 2024). Eligibility required first-time AMC diagnosis without admission VA. Univariate analysis (P < 0.05) and binary logistic regression identified independent VA risk factors. Continuous variables were dichotomized via receiver operating characteristic curves, and a scoring model was constructed, with internal validation of discriminative performance and calibration. Forty-four children (14.1%) developed VA, mostly within the first week. Independent risk factors were cardiac troponin I (cTnI ≥ 0.1945 ng/mL, OR = 9.114), blood urea nitrogen (BUN ≥ 4.55 mmol/L, OR = 9.796), and left ventricular fraction shortening (LVFS ≤ 0.33, OR = 6.005). The model assigned 3 points to cTnI/BUN and 2 to LVFS (total 0–8 points). At cutoff ≥ 4 points: training set (sensitivity = 70.0%, specificity = 90.4%, AUC = 0.871); validation set (sensitivity = 78.6%, specificity = 94.4%, accuracy = 92.3%, AUC = 0.837). Calibration was acceptable (Hosmer-Lemeshow P = 0.288). The cTnI-, BUN-, and LVFS-based scoring model offers a simple, effective tool for early VA risk stratification in children with AMC. It aids targeted monitoring and intervention, improving clinical decision-making. Limitations include retrospective single-center design and small sample size; prospective multicenter validation is needed.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted an observational in Children aged 1 month to 17 years with first diagnosed acute myocarditis without ventricular arrhythmia on admission (n=312). cTnI-, BUN-, and LVFS-based scoring model for early identification of ventricular arrhythmia risk vs. No scoring model (baseline clinical monitoring) was evaluated on Development of ventricular arrhythmia (VA) during hospitalization (OR cTnI ≥ 0.1945 ng/mL=9.114; OR BUN ≥ 4.55 mmol/L=9.796; OR LVFS ≤ 0.33=6.005, p=<0.05 for risk factors). The cTnI-, BUN-, and LVFS-based scoring model identified children with acute myocarditis at risk of ventricular arrhythmia with AUC 0.871 in training and 0.837 in validation sets, sensitivity up to 78.6%, specificity up to 94.4%.
Synapse has enriched 10 related papers. Consider them for comparative context: